Archives of Dermatology · 2001 · 19 citations · 0 references
Veterinary MedicineInfectious DiseasesMicrobiologyAntimicrobial ResistanceAntimicrobial Resistance EpidemiologyMedical MicrobiologyAntibiotic ResistanceBacterial InfectionsGynecologic InfectionsPelvic Inflammatory DiseaseResistance SurveillanceSexually Transmitted InfectionsAntibiotic Therapy For GonorrheaAntimicrobial Resistance In GonorrheaDrug Resistance PatternsGonorrhea EpidemiologyHuman Immunodeficiency Virus TransmissionNeisseria Gonorrhoeae ResistancePelvic Inflammatory Disease ManagementPelvic Inflammatory Disease Sequelae
In 1999, 360,076 cases of gonorrhea were reported in the United States (1). Gonorrhea is a major cause of pelvic inflammatory disease, often leading to ectopic pregnancy and infertility, and it can facilitate human immunodeficiency virus (HIV) transmission (2). During the 1980s, resistance to penicillin and tetracycline among gonococcal isolates became widespread; as a result, CDC recommended that other antimicrobial agents be used to treat gonorrhea. This report summarizes investigations of an increase in fluoroquinolone-resistant Neisseria gonorrhoeae in Hawaii and of a cluster of N. gonorrhoeae infections with decreased susceptibility to azithromycin in Missouri.